Corporate Announcement
Security Code :
532296
Company :
GLENMARK
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Exchange Received Time
19/08/2019 12:07:51
Exchange Disseminated Time
19/08/2019 12:08:01
Time Taken
00:00:10
Glenmark receives approval for combination of Remogliflozin Etabonate and Metformin Hydrochloride for adults with type 2 diabetes in India
Disclaimer
Back To Announcements